Venous thromboembolism (VTE) describes the diagnoses of deep vein thrombosis (DVT) or pulmonary embolism (PE). DVT is the formation of thrombi in the deep veins, most commonly the large veins of the ...
Apixaban 2.5 mg twice daily significantly reduced symptomatic venous thromboembolism (VTE) recurrence, with a low risk of major bleeding, in patients with provoked VTE and enduring risk factors, ...
Dr. Nigel Key and Dr. Anna Falanga join us for a conversation on the updated ASCO VTE prophylaxis and treatment in patients with cancer guideline. They discuss recent evidence assessing apixaban for ...
Osimertinib for Patients With Non–Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Multicenter, Open-Label, Phase II Trial (KCSG-LU15-09) The systematic review included 35 publications on ...
At the dawn of the 21st century, venous thromboembolism (VTE) treatment remained in the dark ages. Backed by an MD and a legacy of paternalistic practice, we convinced patients to do what now seems ...
"We still have a lot of work ahead to define what the most informative prediction/scoring VTE systems are, for both newly diagnosed and relapsed/refractory MM patients, and how we can make them more ...
The American College of Chest Physicians (CHEST) recently released new clinical guidelines for venous thromboembolism (VTE) management, "Antithrombotic Therapy for VTE Disease: Second Update of the ...
Continuing oral anticoagulants (OACs) in unprovoked venous thromboembolism (VTE) beyond the 90-day mark provides substantial protection against VTE recurrence and lowers mortality, benefits that ...
Potentially fatal blood clots, known as venous thromboembolism (VTE), are more likely when you’re hospitalized or part of a high-risk group. Learn how to reduce your risk. Under normal circumstances, ...
Venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE), is a major complication following surgery and in high-risk scenarios. Aspirin may provide an alternative ...
Stakeholders concurred that the occurrence of VTE events is a significant public health concern. According to Ralph J. Riello III, PharmD, “It is a problem often that hospitals do not know that they ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results